杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/03/23 | 1,554 | 1,577 | 1,550 | 1,570 | +25 | +1.6% | 131,000 |
| 2012/03/22 | 1,544 | 1,553 | 1,540 | 1,545 | +1 | +0.1% | 115,000 |
| 2012/03/21 | 1,549 | 1,563 | 1,542 | 1,544 | -13 | -0.8% | 82,000 |
| 2012/03/19 | 1,558 | 1,569 | 1,550 | 1,557 | ±0 | ±0% | 81,000 |
| 2012/03/16 | 1,550 | 1,561 | 1,548 | 1,557 | +11 | +0.7% | 84,000 |
| 2012/03/15 | 1,531 | 1,571 | 1,531 | 1,546 | +16 | +1% | 162,000 |
| 2012/03/14 | 1,544 | 1,545 | 1,510 | 1,530 | +23 | +1.5% | 193,000 |
| 2012/03/13 | 1,522 | 1,530 | 1,503 | 1,507 | -22 | -1.4% | 126,000 |
| 2012/03/12 | 1,530 | 1,537 | 1,525 | 1,529 | ±0 | ±0% | 58,000 |
| 2012/03/09 | 1,535 | 1,539 | 1,526 | 1,529 | -13 | -0.8% | 218,000 |
| 2012/03/08 | 1,541 | 1,566 | 1,528 | 1,542 | +24 | +1.6% | 331,000 |
| 2012/03/07 | 1,507 | 1,522 | 1,498 | 1,518 | +12 | +0.8% | 151,000 |
| 2012/03/06 | 1,498 | 1,510 | 1,493 | 1,506 | +4 | +0.3% | 120,000 |
| 2012/03/05 | 1,505 | 1,525 | 1,490 | 1,502 | +3 | +0.2% | 101,000 |
| 2012/03/02 | 1,467 | 1,508 | 1,467 | 1,499 | +33 | +2.3% | 217,000 |
| 2012/03/01 | 1,447 | 1,466 | 1,432 | 1,466 | +27 | +1.9% | 149,000 |
| 2012/02/29 | 1,464 | 1,475 | 1,437 | 1,439 | -17 | -1.2% | 160,000 |
| 2012/02/28 | 1,457 | 1,468 | 1,447 | 1,456 | +4 | +0.3% | 124,000 |
| 2012/02/27 | 1,451 | 1,454 | 1,440 | 1,452 | +17 | +1.2% | 101,000 |
| 2012/02/24 | 1,461 | 1,466 | 1,422 | 1,435 | -18 | -1.2% | 237,000 |
| 2012/02/23 | 1,450 | 1,461 | 1,439 | 1,453 | -10 | -0.7% | 259,000 |
| 2012/02/22 | 1,431 | 1,468 | 1,431 | 1,463 | +29 | +2% | 144,000 |
| 2012/02/21 | 1,414 | 1,439 | 1,414 | 1,434 | +14 | +1% | 74,000 |
| 2012/02/20 | 1,424 | 1,437 | 1,420 | 1,420 | +5 | +0.4% | 91,000 |
| 2012/02/17 | 1,415 | 1,426 | 1,411 | 1,415 | +5 | +0.4% | 109,000 |
| 2012/02/16 | 1,419 | 1,421 | 1,407 | 1,410 | -6 | -0.4% | 124,000 |
| 2012/02/15 | 1,420 | 1,426 | 1,406 | 1,416 | -4 | -0.3% | 170,000 |
| 2012/02/14 | 1,432 | 1,434 | 1,413 | 1,420 | -12 | -0.8% | 157,000 |
| 2012/02/13 | 1,442 | 1,457 | 1,424 | 1,432 | +6 | +0.4% | 227,000 |
| 2012/02/10 | 1,431 | 1,434 | 1,416 | 1,426 | -5 | -0.3% | 177,000 |
| 2012/02/09 | 1,416 | 1,435 | 1,406 | 1,431 | +1 | +0.1% | 300,000 |
| 2012/02/08 | 1,376 | 1,446 | 1,369 | 1,430 | +66 | +4.8% | 426,000 |
| 2012/02/07 | 1,368 | 1,390 | 1,359 | 1,364 | +8 | +0.6% | 301,000 |
| 2012/02/06 | 1,372 | 1,378 | 1,351 | 1,356 | -15 | -1.1% | 146,000 |
| 2012/02/03 | 1,365 | 1,378 | 1,356 | 1,371 | +6 | +0.4% | 153,000 |
| 2012/02/02 | 1,347 | 1,377 | 1,347 | 1,365 | +18 | +1.3% | 149,000 |
| 2012/02/01 | 1,325 | 1,352 | 1,325 | 1,347 | +22 | +1.7% | 137,000 |
| 2012/01/31 | 1,314 | 1,329 | 1,308 | 1,325 | +11 | +0.8% | 160,000 |
| 2012/01/30 | 1,323 | 1,330 | 1,314 | 1,314 | -8 | -0.6% | 76,000 |
| 2012/01/27 | 1,318 | 1,326 | 1,316 | 1,322 | +4 | +0.3% | 50,000 |
| 2012/01/26 | 1,312 | 1,324 | 1,312 | 1,318 | -2 | -0.2% | 57,000 |
| 2012/01/25 | 1,343 | 1,343 | 1,319 | 1,320 | +5 | +0.4% | 130,000 |
| 2012/01/24 | 1,315 | 1,315 | 1,306 | 1,315 | +1 | +0.1% | 62,000 |
| 2012/01/23 | 1,312 | 1,320 | 1,307 | 1,314 | +3 | +0.2% | 81,000 |
| 2012/01/20 | 1,312 | 1,323 | 1,307 | 1,311 | +9 | +0.7% | 83,000 |
| 2012/01/19 | 1,311 | 1,316 | 1,300 | 1,302 | -8 | -0.6% | 61,000 |
| 2012/01/18 | 1,300 | 1,320 | 1,299 | 1,310 | -7 | -0.5% | 64,000 |
| 2012/01/17 | 1,317 | 1,324 | 1,306 | 1,317 | ±0 | ±0% | 60,000 |
| 2012/01/16 | 1,321 | 1,322 | 1,305 | 1,317 | -6 | -0.5% | 53,000 |
| 2012/01/13 | 1,319 | 1,330 | 1,316 | 1,323 | +5 | +0.4% | 52,000 |
3101～
3150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.27倍 | 1.47倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
